194 results on '"Rosati, Emanuela"'
Search Results
2. GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL
3. NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models
4. NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential
5. Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
6. Therapeutic targeting of chronic lymphocytic leukemia by silver nanoparticles
7. NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.
8. Figure S10 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
9. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation
10. Immune correlates of protection by vaccine against SARS‐CoV ‐2 in patients with chronic lymphocytic leukaemia
11. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation
12. Impairment of brain mitochondrial functions by β-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine
13. Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL
14. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
15. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo
16. NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion
17. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
18. NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status
19. Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
20. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation
21. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL
22. Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
23. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation
24. B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α
25. Graft engineering for allogeneic haploidentical stem cell transplantation
26. Effect of trichostatin a and 5′-azacytidine on transgene reactivation in U937 transduced cells
27. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells
28. NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells
29. NOTCH and Graft-Versus-Host Disease
30. NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
31. NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells
32. Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation
33. Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction
34. NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells
35. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL
36. Macrophage induced gelsolin in response to Group BStreptococcus(GBS) infection
37. B-chronic lymphocytic leukemia cells exert in vitro cytotoxicity mediated by tumor necrosis factor alpha
38. Is thiol supplementation for potentiang antioxidant defenses a harmless strategy?
39. L’N-Acetil-L-cisteina inibisce l’apoptosi di linfociti B umani regolando l’attivazione di diverse vie di trasduzione del segnale
40. Regolazione redox dell'apoptosi di linfociti B umani
41. Macrophage apoptosis induced by Group B Streptococcus
42. Inhibition activity of human cytolytic lymphocytes in vitro by omeprazole
43. Development of an IFN-γ producing human NK cell subset
44. Expression of killer inhibitory receptor molecules during human NK cell differentiation
45. Effetti dell’infezione intracellulare da streptococco di gruppo B sierotipo Ia nel macrofago
46. A novelNOTCH1PEST domain mutation in a case of chronic lymphocytic leukemia
47. γ‐Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down‐regulation
48. Pathogenic effects of group B streptococcus on macrophages
49. Inibizione in vitro dell’attività citotossica dei linfociti citolitici da parte dell’omeprazolo
50. Eventi immunologici precoci nella risposta immune alla C. albicans inattivata
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.